Form 8-K - Current report:
SEC Accession No. 0001564590-21-030940
Filing Date
2021-06-01
Accepted
2021-06-01 07:09:32
Documents
13
Period of Report
2021-06-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alks-8k_20210601.htm   iXBRL 8-K 41224
2 EX-99.1 alks-ex991_15.htm EX-99.1 66719
  Complete submission text file 0001564590-21-030940.txt   253132

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alks-20210601.xsd EX-101.SCH 5776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alks-20210601_lab.xml EX-101.LAB 19413
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alks-20210601_pre.xml EX-101.PRE 11606
6 EXTRACTED XBRL INSTANCE DOCUMENT alks-8k_20210601_htm.xml XML 3531
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 21982933
SIC: 2834 Pharmaceutical Preparations